Dashboard
Manage Tickers

QUREuniQure N.V.

Nasdaq uniqure.com


$ 5.41 $ -0.11 (-1.99 %)    

Friday, 06-Sep-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 5.42
$ 5.40 x 144
-- x --
-- - --
$ 3.73 - $ 11.35
301,964
na
263.94M
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-01-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 02-27-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-02-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 10-25-2021 09-30-2021 10-Q
13 07-26-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 10-27-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 04-29-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 10-28-2019 09-30-2019 10-Q
21 07-29-2019 06-30-2019 10-Q
22 04-29-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 04-30-2018 03-31-2018 10-Q
27 03-14-2018 12-31-2017 10-K
28 11-01-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 03-15-2017 12-31-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-uniqure-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on uniQ...
08/20/2024 10:28:22

HC Wainwright & Co. analyst Patrick Trucchio reiterates uniQure (NASDAQ:QURE) with a Buy and maintains $25 price target.

uniqure-doses-first-patient-in-phase-iiia-clinical-trial-of-amt-191-for-fabry-disease
uniQure Doses First Patient In Phase I/IIa...
08/15/2024 11:09:57

goldman-sachs-maintains-neutral-on-uniqure-raises-price-target-to-10
Goldman Sachs Maintains Neutral on uniQure...
08/02/2024 17:00:13

Goldman Sachs analyst Salveen Richter maintains uniQure (NASDAQ:QURE) with a Neutral and raises the price target from $6 to ...

uniqures-cash-position-of-approximately-524m-as-of-june-30-2024-expected-to-fund-operations-through-the-end-of-2027
uniQure's Cash Position Of Approximately $...
08/01/2024 12:00:23

uniqure-q2-2024-gaap-eps-116-inline-sales-11126m-beat-6260m-estimate
uniQure Q2 2024 GAAP EPS $(1.16), Inline, ...
08/01/2024 11:59:59

cantor-fitzgerald-reiterates-overweight-on-uniqure-maintains-24-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/16/2024 13:13:47

Cantor Fitzgerald analyst Kristen Kluska reiterates uniQure (NASDAQ:QURE) with a Overweight and maintains $24 price target.

why-conagra-brands-shares-are-trading-lower-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why ConAgra Brands Shares Are Trading Lowe...
07/11/2024 18:02:49

why-are-uniqure-shares-surging-today
Why Are UniQure Shares Surging Today?
07/10/2024 20:00:11

UniQure N.V. (NASDAQ: QURE) shares are skyrocketing Wednesday following the release of promising interim data from its Phase I/...

why-seastar-medical-holding-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why SeaStar Medical Holding Shares Are Tra...
07/10/2024 17:18:59

smart-global-posts-upbeat-results-joins-aehr-test-systems-marinemax-and-other-big-stocks-moving-higher-on-wednesday
SMART Global Posts Upbeat Results, Joins A...
07/10/2024 14:48:49

kura-sushi-posts-weak-q3-results-joins-legalzoomcom-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Kura Sushi Posts Weak Q3 Results, Joins Le...
07/10/2024 12:01:12

sp-500-edges-higher-indivior-shares-plummet
S&P 500 Edges Higher; Indivior Shares Plummet
07/09/2024 18:38:34

why-helen-of-troy-shares-are-trading-lower-by-around-30-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Helen of Troy Shares Are Trading Lower...
07/09/2024 16:59:31

crude-oil-down-1-soligenix-shares-surge
Crude Oil Down 1%; Soligenix Shares Surge
07/09/2024 16:11:44

hc-wainwright--co-reiterates-buy-on-uniqure-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on uniQ...
07/09/2024 15:57:33

HC Wainwright & Co. analyst Patrick Trucchio reiterates uniQure (NASDAQ:QURE) with a Buy and maintains $25 price target.

why-uniqure-stock-is-soaring
Why UniQure Stock Is Soaring
07/09/2024 15:55:47

UniQure shares are trading higher Tuesday after the company announced updated interim data from its ongoing U.S. and European P...

dow-falls-over-50-points-us-small-business-optimism-surges-in-june
Dow Falls Over 50 Points; US Small Busines...
07/09/2024 13:42:27

uniqures-huntingtons-disease-gene-therapy-shows-interim-results-at-24-months
uniQure's Huntington's Disease Gene Therap...
07/09/2024 11:09:30

uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical ...

genezen-to-acquire-uniqures-commercial-gene-therapy-manufacturing-operations-in-lexington-ma-financial-terms-undisclosed
Genezen to Acquire uniQure's Commercial Ge...
07/01/2024 11:14:28

Genezen, a best-in-class gene therapy CDMO, today announced an agreement to acquire uniQure's (NASDAQ:QURE) commercial gene...

fda-grants-rmat-status-to-uniqures-amt-130-gene-therapy-for-huntingtons-disease
FDA Grants RMAT Status to UniQure's AMT-13...
06/03/2024 11:17:51

uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION